These results, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 help the principle of concentrating on ACKR3 as a unique strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated Ailments. These results counsel that https://josephg913cvn8.dm-blog.com/profile